1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Full Proposals Due June 16, 2026 at 5 p.m. US ET. Award announcement anticipated week of September 28, 2026.
"Access Advocate for Clinical Research Participation" is currently closed and not accepting applications.
Access Advocate for Clinical Research Participation is sponsored by The Michael J. Fox Foundation for Parkinson's Research. The Access Advocate for Clinical Research Participation grant is funded by The Michael J.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Access Advocate for Clinical Research Participation | Parkinson's Disease Your actions are amplified during Parkinson's Awareness Month. Donate now to accelerate promising research that can't wait. Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close Access Advocate for Clinical Research Participation Access Advocate for Clinical Research Participation This program will support implementation and evaluation of a Parkinson’s disease (PD) focused Access Advocate model designed to increase inclusive research participation.
Funding will support Access Advocates at clinical sites to build practical, relationship based pathways to improving representative research enrollment and retention. MJFF will prioritize proposals that: Demonstrate strong PD study volume, including interventional clinical trials, and readiness to support study referrals. Establish well defined Access Advocate role with appropriate training and supervision.
Implement repeatable workflows for identifying potential participants, assessing barriers, connecting people to resources and follow-up. Include a feasible plan to track recruitment, retention, and barrier related metrics and site-relevant health system outcomes. Show Access Advocates' effect on recruiting and retaining underrepresented groups in PD studies.
Commit to participating in cross-site learnings to share insights and improve the Access Advocate model. Download the program overview for a detailed list of proposal evaluation criteria. MJFF will NOT consider proposals from sites: Outside of the US and Canada.
Without active or planned interventional PD clinical trials. Proposing a model centered primarily on broad community outreach rather than clinic and trial connected access advocacy. Important notice: MJFF will be conducting two Q&A sessions to answer any questions related to the RFA on: Monday, May 11 at 1:00 p.
m. US ET Friday, May 15 at 2:00 p. m.
US ET Please note that MJFF has an Open Science Policy which governs research outputs (such as preprints, journal articles, data, code, and software) resulting from MJFF-funded work. The Open Science Policy applies to this funding program and includes specific rules, timing, and format for the return of those research outputs and requires them to be shared openly, to be free to access, and with persistent identifiers.
Please contact openscience@michaeljfox. org for questions about the Open Science Policy. Here.
Until Parkinson's isn't. Help us speed a cure for the 6 million people worldwide living with Parkinson's. Join our email list to get the latest news and resources directly to your inbox.
Connection to Parkinson's Immediate family member has PD Immediate family member had PD Extended family member or friend has PD Extended family member or friend had PD I am a researcher, clinician or work with the PD community What Year Were You Diagnosed with PD?
Scoring criteria used to review proposals for this grant.
According to the current listing, eligibility includes: Clinical sites located in the US or Canada with active or planned interventional Parkinson's disease clinical trials; model must be centered on clinic and trial-connected access advocacy rather than broad community outreach. Confirm the full requirements in the official notice before applying.
The current listing shows $200,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 16, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Access Advocate for Clinical Research Participation is funded by The Michael J. Fox Foundation for Parkinson's Research. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.